醫美成新方向,蘇寧環球(000718.SZ)近一個月股價翻倍!
格隆匯5月28日丨蘇寧環球(000718.SZ)上午盤中封漲停板,報價10.76元,創2016年以來新高,最新市值327億元。該股自4月27日啟動上漲行情至今的1個月,股價已累漲117%。蘇寧環球5月24日稱,公司在房地產業務穩健發展的同時,正積極開拓產業轉型發展道路,全力推進醫美產業發展壯大。對於醫美產業的發展,公司目前主要以併購的方式增厚業績。集團於2016年出資成立了50億元規模的醫美產業基金,至今該基金已擁有5家醫美醫院。蘇寧環球的醫美醫院集中於一、二線城市,下一步將在全國範圍內進行優質標的的尋找。公司表示,隨着醫美產業的不斷壯大,蘇寧環球未來將成為以醫美產業為主營業務的上市公司。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.